$2.50
0.020.81%
After Hours: Mar 31, 4:01 PM EDT
Comments
Loading...
Orgenesis Earnings Estimates, EPS & Revenue | OTC:ORGS | Benzinga
Orgenesis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-1.930
Quarterly Revenue
$347.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$899.00K
Analyze the earnings history of Orgenesis using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORGS | Orgenesis | -$2.90 | — | — | — | $141.00K | — | — | — | 05/20/2025 | Get Alert |
| ORGS | Orgenesis | -$2.10 | — | — | — | $165.00K | — | — | — | 05/06/2025 | Get Alert |
| ORGS | Orgenesis | -$4.30 | — | -$1.93 | — | $110.00K | — | $347.00K | — | 11/13/2024 | Get Alert |
| ORGS | Orgenesis | -$1.50 | — | -$2.30 | — | $6.97M | — | $246.00K | — | 08/08/2024 | Get Alert |
| ORGS | Orgenesis | $1.70 | $0.00 | -$2.90 | -100.00% | $7.04M | $12.00M | $141.00K | -98.83% | 05/21/2024 | Get Alert |
| ORGS | Orgenesis | -$1.60 | — | -$2.10 | — | $13.60M | — | $165.00K | — | 04/15/2024 | Get Alert |
| ORGS | Orgenesis | -$0.50 | $1.00 | -$4.30 | -530.00% | $7.84M | $13.50M | $110.00K | -99.19% | 11/13/2023 | Get Alert |
| ORGS | Orgenesis | -$2.20 | $0.00 | -$1.50 | -100.00% | $7.20M | $10.70M | $6.97M | -34.81% | 08/11/2023 | Get Alert |
| ORGS | Orgenesis | -$1.60 | $0.50 | $1.70 | 240.00% | $7.21M | $9.90M | $7.04M | -28.85% | 05/10/2023 | Get Alert |
| ORGS | Orgenesis | -$2.00 | $0.00 | -$1.60 | -100.00% | $6.89M | $8.30M | $13.60M | 63.86% | 03/21/2023 | Get Alert |
| ORGS | Orgenesis | -$4.20 | -$0.20 | -$0.50 | -150.00% | $8.68M | $7.30M | $7.84M | 7.41% | 11/10/2022 | Get Alert |
| ORGS | Orgenesis | -$1.10 | -$0.20 | -$2.20 | -1000.00% | $10.54M | $7.00M | $7.20M | 2.87% | 08/16/2022 | Get Alert |
| ORGS | Orgenesis | $0.10 | -$0.40 | -$1.60 | -300.00% | $9.39M | — | $7.21M | — | 05/24/2022 | Get Alert |
| ORGS | Orgenesis | $23.30 | — | -$2.00 | — | $2.30M | $9.00M | $6.89M | -23.42% | 03/30/2022 | Get Alert |
| ORGS | Orgenesis | $4.30 | -$0.30 | -$4.20 | -1300.00% | $1.73M | $9.00M | $8.68M | -3.60% | 11/04/2021 | Get Alert |
| ORGS | Orgenesis | -$12.60 | -$2.30 | -$1.10 | 52.17% | $1.75M | $3.30M | $10.54M | 219.55% | 08/05/2021 | Get Alert |
| ORGS | Orgenesis | -$3.90 | -$2.30 | $0.10 | 104.35% | $1.88M | $3.30M | $9.39M | 184.52% | 05/07/2021 | Get Alert |
| ORGS | Orgenesis | $4.20 | — | $23.30 | — | $9.08M | $11.40M | $2.30M | -79.86% | 03/09/2021 | Get Alert |
| ORGS | Orgenesis | $4.40 | — | $4.30 | — | $9.12M | — | $1.73M | — | 11/05/2020 | Get Alert |
| ORGS | Orgenesis | — | — | -$12.60 | — | — | — | $1.75M | — | 08/07/2020 | Get Alert |
| ORGS | Orgenesis | — | — | -$3.90 | — | — | — | $1.88M | — | 05/11/2020 | Get Alert |
Orgenesis (ORGS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-21 | $-2.90 | $0 | -100.0 % |
| Q3 | 2023-11-13 | $-4.30 | $1.00 | -530.0 % |
| Q2 | 2023-08-11 | $-1.50 | $0 | -100.0 % |
| Q1 | 2023-05-10 | $1.70 | $0.50 | 240.0 % |
Orgenesis (ORGS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-21 | $141.00K | $12.00M | -98.8 % |
| Q3 | 2023-11-13 | $110.00K | $13.50M | -99.2 % |
| Q2 | 2023-08-11 | $6.98M | $10.70M | -34.8 % |
| Q1 | 2023-05-10 | $7.04M | $9.90M | -28.8 % |
FAQ
When is Orgenesis (OTCQX:ORGS) reporting earnings?
Orgenesis (ORGS) is scheduled to report earnings on May 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Orgenesis (OTCQX:ORGS)?
The Actual EPS was $-1.93, which missed the estimate of $0.00.
What were Orgenesis’s (OTCQX:ORGS) revenues?
The Actual Revenue was $347K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
